Thus, therapeutic approaches that promote lipid breakdown or restore microglial glucose and mitochondrial metabolism are becoming more and more viable options for improving Aβ/tau clearance and preventing neuroinflammation in AD. Here, MAPT is linked to Alzheimer disease.